oral semaglutide trials Updates in Medicine | 🩺 Cuts CV Risk in High-Risk T2DM – SOUL Trial (NEJM, Mar 2025) 🔗 Original article link in bio 📌 Key Highlights: 🔹 Overview of the PIONEER Clinical

Yale researchers have discovered that GLP-1 receptor agonist drugs, like Ozempic and Wegovy, may offer promising new ways of treating alcohol use disorder.

Yes, weight loss injections such as Mounjaro and Wegovy can still be used during hot weather, but extra care is needed

These weight loss drugs, which use

Discover when GLP-1 medications like Ozempic and Wegovy start working for diabetes and weight loss

90% of women saw improvement in skin elasticity, 95% of women said their skin felt smoother and 85% of women experienced brighter skin

In Study 1, the GLP-1 target was evaluated more negatively than the diet/exercise target and the no weight loss target